Dr. Jonathan King, OD

NPI: 1033789763
Total Payments
$17,279
2024 Payments
$5,629
Companies
10
Transactions
80
Medicare Patients
156
Medicare Billing
$9,224

Payment Breakdown by Category

Travel$7,157 (41.4%)
Other$4,463 (25.8%)
Consulting$3,392 (19.6%)
Food & Beverage$2,268 (13.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $7,157 19 41.4%
Compensation for serving as faculty or as a speaker for a medical education program $4,025 4 23.3%
Consulting Fee $3,392 10 19.6%
Food and Beverage $2,268 44 13.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $400.00 2 2.3%
Entertainment $37.55 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Bausch & Lomb Americas Inc. $12,031 49 $0 (2024)
Valley Contax, Inc. $3,471 3 $0 (2022)
Alcon Vision LLC $519.61 10 $0 (2024)
Johnson & Johnson Vision Care, Inc. $406.67 4 $0 (2022)
CooperVision Inc. $406.66 4 $0 (2022)
Amgen Inc. $111.76 5 $0 (2024)
ABBVIE INC. $110.02 2 $0 (2024)
Oyster Point Pharma, Inc. $98.56 1 $0 (2022)
Allergan, Inc. $77.95 1 $0 (2022)
GLAUKOS CORPORATION $46.31 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,629 29 Bausch & Lomb Americas Inc. ($5,460)
2023 $4,297 16 Bausch & Lomb Americas Inc. ($4,132)
2022 $6,744 29 Valley Contax, Inc. ($3,471)
2021 $609.51 6 Alcon Vision LLC ($203.17)

All Payment Transactions

80 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/01/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $26.29 General
Category: Inflammation/Rare Disease
10/18/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $16.78 General
Category: Ophthalmology
09/24/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $22.48 General
Category: Inflammation/Rare Disease
08/20/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $22.25 General
Category: Inflammation/Rare Disease
08/12/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $3,025.00 General
Category: Ophthalmology
08/05/2024 Bausch & Lomb Americas Inc. ALDEN SCLERAL ZENLENS (Device) Food and Beverage In-kind items and services $22.16 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Travel and Lodging Cash or cash equivalent $266.96 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Travel and Lodging Cash or cash equivalent $202.86 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Travel and Lodging Cash or cash equivalent $84.42 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Food and Beverage In-kind items and services $50.00 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Travel and Lodging Cash or cash equivalent $48.97 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Travel and Lodging Cash or cash equivalent $47.25 General
Category: Ophthalmology
07/25/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Food and Beverage In-kind items and services $10.79 General
Category: Ophthalmology
07/24/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Food and Beverage In-kind items and services $22.74 General
Category: Ophthalmology
07/24/2024 Bausch & Lomb Americas Inc. VYZULTA (Drug) Food and Beverage In-kind items and services $20.85 General
Category: Ophthalmology
06/17/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $200.00 General
Category: Ophthalmology
06/17/2024 Bausch & Lomb Americas Inc. ZENLENS (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $200.00 General
Category: Ophthalmology
04/15/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $17.68 General
Category: Ophthalmology
04/15/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $13.99 General
Category: Inflammation/Rare Disease
03/25/2024 Bausch & Lomb Americas Inc. Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $600.00 General
03/25/2024 Bausch & Lomb Americas Inc. Travel and Lodging Cash or cash equivalent $96.18 General
03/25/2024 Bausch & Lomb Americas Inc. Travel and Lodging Cash or cash equivalent $81.74 General
03/25/2024 Bausch & Lomb Americas Inc. Travel and Lodging Cash or cash equivalent $70.81 General
03/25/2024 Bausch & Lomb Americas Inc. Travel and Lodging Cash or cash equivalent $57.13 General
03/25/2024 Bausch & Lomb Americas Inc. Food and Beverage In-kind items and services $17.51 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 96 100 $15,800 $6,080
2022 3 47 82 $3,488 $2,248
2021 1 13 14 $1,120 $896.00
Total Patients
156
Total Services
196
Medicare Billing
$9,224
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 22 25 $4,000 $1,921 48.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 18 18 $4,410 $1,622 36.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 28 29 $3,335 $1,552 46.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 15 15 $2,430 $678.32 27.9%
92250 Photography of the retina Office 2023 13 13 $1,625 $306.26 18.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 26 $2,080 $1,254 60.3%
83861 Microfluid analysis of tears Office 2022 15 32 $928.00 $718.04 77.4%
83516 Analysis of substance using immunoassay technique, multiple step method Office 2022 12 24 $480.00 $276.24 57.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 13 14 $1,120 $896.00 80.0%

About Dr. Jonathan King, OD

Dr. Jonathan King, OD is a Optometrist healthcare provider based in South Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2021. The National Provider Identifier (NPI) number assigned to this provider is 1033789763.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan King, OD has received a total of $17,279 in payments from pharmaceutical and medical device companies, with $5,629 received in 2024. These payments were reported across 80 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($7,157).

As a Medicare-enrolled provider, King has provided services to 156 Medicare beneficiaries, totaling 196 services with total Medicare billing of $9,224. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Location South Ogden, UT
  • Active Since 06/25/2021
  • Last Updated 10/09/2025
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • NPI Number 1033789763

Products in Payments

  • ZENLENS (Device) $8,532
  • AIR OPTIX (Device) $406.67
  • Acuvue (Device) $406.67
  • Clariti Contact Lens (Device) $406.66
  • ALDEN SCLERAL ZENLENS (Device) $163.75
  • TOTAL30 (Device) $112.94
  • TYRVAYA (Drug) $98.56
  • VUITY (Drug) $77.95
  • XEN GLAUCOMA TREATMENT SYSTEM (Device) $76.67
  • KRYSTEXXA (Biological) $75.29
  • KXL SYSTEM (Device) $46.31
  • XIIDRA (Drug) $40.42
  • VYZULTA (Drug) $38.72
  • TEPEZZA (Biological) $36.47
  • MIEBO (Drug) $35.11
  • LUMIGAN (Drug) $33.35

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in South Ogden